Article Details

Molecure doses first UK subject in Phase II pulmonary sarcoidosis trial

Retrieved on: 2024-03-25 16:44:40

Tags for this article:

Click the tags to see associated articles and topics

Molecure doses first UK subject in Phase II pulmonary sarcoidosis trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. This double-blind, randomised, placebo-controlled, multicentre trial is designed to ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up